Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
Clinical trial NCT06564974 · RECRUITING
Trial details
- NCT number
- NCT06564974
- Sponsor
- Catalyst Pharmaceuticals, Inc.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-09-25
- Primary completion
- 2032-02-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.